Is Neil Woodford stock Provident Financial plc poised for a monster turnaround?

With its core business trending in the right direction, will 2018 be a year of huge returns for Provident Financial plc (LON: PFG)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s been a bruising few months for Neil Woodford as big stakes in companies as diverse as roadside assistance firm AA to drug-maker Astra Zeneca have turned sour to varying degrees. But perhaps his most high profile bet to go sideways has been on subprime lender Provident Financial (LSE: PFG), whose share price has shrunk by 70% over the past year. But with Woodford still holding a large stake in this business, should retail investors bet on a big turnaround from it in 2018?

Well, the good news is that the company’s core doorstep lending division is making a rebound from a very low base. In December collections performance had increased to 78%, up from 65% in September and 57% in August as the company hired back 300 former self-employed agents on a part-time basis.

Divisional losses still came in at the high end of guidance due to the costs from the tumultuous changes in operating style. But with agents back on the street, the business is moving in the right direction again as new loans are extended and old ones are collected.

Furthermore, with the company now valued at only 7.3 times 2018 consensus earnings, there’s very little possible upside priced into its shares. Unfortunately, I believe this negativity may be warranted as the Financial Conduct Authority continues its investigation into the group’s highly profitable Vanquis credit card arm and has recently opened one into its Moneybarn auto loan division.

When the FCA opened an investigation “in relation to the processes applied to customer affordability assessments for vehicle finance and the treatment of customers in financial difficulties,” I saw reason to be nervous. It makes me believe similar issues may be lurking in other parts of the business, or at the very least that the FCA will be poking around to find them.

While I’ve long backed Provident due to its market-leading position, ability to build profitable growth throughout the economic cycle and return gobs of cash to shareholders, the combination of self-inflicted operational problems and heightened regulatory scrutiny is enough to stop me from using this opportunity to begin a stake in the business.

Growth and dividends at a low price

One Woodford holding that’s run into problems but is far more interesting to me is Card Factory (LSE: CARD). The company warned in October that it would experience little-to-no EBITDA growth for the year as it decided to absorb the costs of input and wage inflation rather than pass these on to customers.

While flat profits aren’t great, I believe this period gives it the chance to accelerate its market share gains at the expense of rivals, who unlike Card Factory don’t own their own manufacturing and thus have much higher costs.

Indeed, this process is already occurring with it posting like-for-like growth of 2.7% in the 11 months to December and total sales growth of 5.9% due to new store openings. With management targeting 50 new stores a year and same-store sales growth accelerating, I believe Card Factory’s decision will be vindicated as it pushes competitors out of the market.

This growth potential alongside industry-leading margins, low debt, a 4.65% dividend yield and low valuation of just 10.7 times forward earnings make this one Woodford holding I’d love to own for the long term.

Ian Pierce has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

ChatGPT thinks these are the 5 best FTSE stocks to consider buying for 2026!

Can the AI bot come up trumps when asked to select the best FTSE stocks to buy as we enter…

Read more »

Investing For Beginners

How much do you need in an ISA to make the average UK salary in passive income?

Jon Smith runs through how an ISA can help to yield substantial income for a patient long-term investor, and includes…

Read more »

Investing Articles

3 FTSE 250 shares to consider for income, growth, and value in 2026!

As the dawn of a new year in the stock market approaches, our writer eyes a trio of FTSE 250…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Want to be a hit in the stock market? Here are 3 things super-successful investors do

Dreaming of strong performance when investing in the stock market? Christopher Ruane shares a trio of approaches used by some…

Read more »

Two white male workmen working on site at an oil rig
Investing Articles

The BP share price has been on a roller coaster, but where will it go next?

Analysts remain upbeat about 2026 prospects for the BP share price, even as an oil glut threatens and the price…

Read more »

Investing Articles

Prediction: move over Rolls-Royce, the BAE share price could climb another 45% in 2026

The BAE Systems share price has had a cracking run in 2025, but might the optimism be starting to slip…

Read more »

Tesla car at super charger station
Investing Articles

Will 2026 be make-or-break for the Tesla share price?

So what about the Tesla share price: does it indicate a long-term must-buy tech marvel, or a money pit for…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Apple CEO Tim Cook just put $3m into this S&P 500 stock! Time to buy?

One household-name S&P 500 stock has crashed 65% inside five years. Yet Apple's billionaire CEO sees value and has been…

Read more »